Institute for Research in Biomedicine (IRB Barcelona), Institute for Advanced Chemistry of Catalonia (IQAC-CSIC), Networking Centre on Bioengineering, Biomaterials and Nanomedicine (CIBER-BBN), Baldiri Reixac 10, 08028 Barcelona, Spain.
Mol Divers. 2011 Aug;15(3):751-7. doi: 10.1007/s11030-011-9305-6. Epub 2011 Jan 26.
Oligoribonucleotide conjugates and the corresponding siRNA duplexes against tumor necrosis factor carrying one, two, or four glucose and galactose residues at the 5'-end have been prepared using phosphoramidite chemistry. Carbohydrate-modified siRNA duplexes have similar inhibitory properties than unmodified RNA duplexes in HeLa cells transfected with oligofectamine. When HeLa cells were treated with siRNA carrying one, two, or four glucose residues without oligofectamine, no inhibition was observed. The inhibitory properties of siRNA carrying galactose residues without transfecting agent were tested on HuH-7 cells that have abundant asialoglycoprotein receptors. In these cells siRNA carrying galactose residues have slight anti-TNF inhibitory properties (25% in the best case) that are eliminated if the receptors are blocked with a competitor. These results demonstrate receptor-mediated uptake of siRNA carrying galactose residues, although the efficacy of the process is not enough for efficient RNA interference experiments.
已使用亚磷酰胺化学法制备了带有一个、两个或四个葡萄糖和半乳糖残基的寡核苷酸缀合物和相应的针对肿瘤坏死因子的 siRNA 双链体,在转染寡聚胺的 HeLa 细胞中,糖修饰的 siRNA 双链体与未修饰的 RNA 双链体具有相似的抑制特性。当 HeLa 细胞用不带寡聚胺的带有一个、两个或四个葡萄糖残基的 siRNA 处理时,没有观察到抑制作用。在具有丰富的去唾液酸糖蛋白受体的 HuH-7 细胞上测试了不带转染剂的带有半乳糖残基的 siRNA 的抑制特性。在这些细胞中,带有半乳糖残基的 siRNA 具有轻微的抗 TNF 抑制特性(在最佳情况下为 25%),如果用竞争物阻断受体,则该抑制特性被消除。这些结果表明,尽管该过程的功效不足以进行有效的 RNA 干扰实验,但带有半乳糖残基的 siRNA 可通过受体介导的摄取。